Citi and others are bullish on biotech, medtech and more

Citi and others are bullish on biotech, medtech and more

2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. “Emerging from a poor capital raising environment in ’22-23, where early-stage biotech companies grappled to fund their Research and Development efforts amid rising interest rates,…

We like health-care stocks in 2024 despite presidential election year weakness

We like health-care stocks in 2024 despite presidential election year weakness

As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector…

Sunak ‘not worried’ about Covid inquiry seeing messages

Sunak ‘not worried’ about Covid inquiry seeing messages

BBC political editor Chris Mason asked Rishi Sunak if the government was challenging the full release of messages between ministers and officials during the pandemic, to the Covid inquiry, because he was worried about something embarrassing him. The PM said: “Not at all”. He said it was “right that we learn the lessons of Covid”…

Sunak ‘not worried’ about Covid inquiry seeing messages

Sunak ‘not worried’ about Covid inquiry seeing messages

BBC political editor Chris Mason asked Rishi Sunak if the government was challenging the full release of messages between ministers and officials during the pandemic, to the Covid inquiry, because he was worried about something embarrassing him. The PM said: “Not at all”. He said it was “right that we learn the lessons of Covid”…

End of content

End of content